Rafferty Asset Management, LLC Protagonist Therapeutics, Inc Transaction History

Rafferty Asset Management, LLC

$29.4 Billion
Q2 2025

A detailed history of Rafferty Asset Management, LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 80,543 shares of PTGX stock, worth $6.26 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

80,543

Previous 44,257 81.99%

Holding current value

$6.26 Million

Previous $2.14 Million 107.99%

% of portfolio

0.02%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$40.89 - $56.37 $1.48 Million - $2.05 Million	36,286 Added 81.99%	80,543 $4.45 Million
Q1 2025 May 14, 2025	SELL	$35.09 - $59.76 $1.8 Million - $3.06 Million	-51,210 Reduced 53.64%	44,257 $2.14 Million
Q4 2024 Feb 14, 2025	BUY	$38.51 - $48.43 $215,309 - $270,772	5,591 Added 6.22%	95,467 $3.69 Million
Q3 2024 Nov 13, 2024	BUY	$33.72 - $47.33 $492,514 - $691,301	14,606 Added 19.4%	89,876 $4.04 Million
Q2 2024 Aug 13, 2024	SELL	$24.66 - $34.8 $4.04 Million - $5.71 Million	-163,938 Reduced 68.53%	75,270 $2.61 Million
Q1 2024 May 13, 2024	BUY	$21.79 - $32.15 $1.56 Million - $2.3 Million	71,413 Added 42.56%	239,208 $6.92 Million
Q4 2023 Feb 13, 2024	SELL	$14.05 - $23.44 $2.56 Million - $4.28 Million	-182,486 Reduced 52.1%	167,795 $3.85 Million
Q3 2023 Nov 13, 2023	BUY	$16.68 - $23.66 $1.08 Million - $1.53 Million	64,822 Added 22.71%	350,281 $5.84 Million
Q2 2023 Aug 11, 2023	BUY	$18.02 - $29.36 $2.38 Million - $3.88 Million	132,072 Added 86.1%	285,459 $7.88 Million
Q1 2023 May 11, 2023	SELL	$10.78 - $25.38 $1.53 Million - $3.6 Million	-141,961 Reduced 48.07%	153,387 $3.53 Million
Q4 2022 Feb 13, 2023	SELL	$7.36 - $11.17 $379,680 - $576,226	-51,587 Reduced 14.87%	295,348 $3.22 Million
Q3 2022 Nov 14, 2022	BUY	$7.86 - $11.71 $257,045 - $382,952	32,703 Added 10.41%	346,935 $2.93 Million
Q2 2022 Aug 12, 2022	BUY	$7.06 - $25.52 $749,334 - $2.71 Million	106,138 Added 51.0%	314,232 $2.49 Million
Q1 2022 May 13, 2022	BUY	$23.34 - $36.08 $987,795 - $1.53 Million	42,322 Added 25.53%	208,094 $4.93 Million
Q4 2021 Feb 10, 2022	BUY	$17.63 - $37.1 $1.7 Million - $3.59 Million	96,642 Added 139.8%	165,772 $5.67 Million
Q3 2021 Nov 10, 2021	BUY	$12.95 - $49.69 $387,697 - $1.49 Million	29,938 Added 76.39%	69,130 $1.23 Million
Q2 2021 Aug 10, 2021	SELL	$25.57 - $44.88 $940,566 - $1.65 Million	-36,784 Reduced 48.42%	39,192 $1.76 Million
Q1 2021 May 10, 2021	BUY	$19.02 - $31.15 $1.18 Million - $1.93 Million	62,102 Added 447.61%	75,976 $1.97 Million
Q4 2020 Feb 10, 2021	SELL	$18.49 - $25.13 $261,189 - $354,986	-14,126 Reduced 50.45%	13,874 $280,000
Q3 2020 Nov 13, 2020	BUY	$15.19 - $22.4 $425,320 - $627,200	28,000 New	28,000 $547,000

Others Institutions Holding PTGX

# of Institutions

297

Shares Held

67.4M

Call Options Held

290K

Put Options Held

318K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $3.81B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Protagonist Therapeutics, Inc Transaction History